COMERICA BANK - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.

Quarter-by-quarter ownership
COMERICA BANK ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q4 2022$18,392
-99.8%
153,719
+36.5%
0.14%
+41.6%
Q3 2022$12,033,000
+25.4%
112,607
+3.2%
0.10%
+27.8%
Q2 2022$9,593,000
-2.2%
109,087
+21.9%
0.08%
+11.3%
Q1 2022$9,806,000
-1.3%
89,477
+2.3%
0.07%
-2.7%
Q4 2021$9,933,000
+1.0%
87,450
+28.5%
0.07%
+23.7%
Q3 2021$9,839,000
+14.3%
68,039
-5.9%
0.06%
+15.7%
Q2 2021$8,606,000
+47.8%
72,271
+63.9%
0.05%
+45.7%
Q1 2021$5,823,000
+25.2%
44,091
+52.3%
0.04%
+16.7%
Q4 2020$4,651,000
+73.1%
28,948
+72.1%
0.03%
+50.0%
Q3 2020$2,687,000
+24.0%
16,823
+10.6%
0.02%
+17.6%
Q2 2020$2,167,000
+18.8%
15,206
+8.0%
0.02%0.0%
Q1 2020$1,824,000
+464.7%
14,083
+483.9%
0.02%
+750.0%
Q4 2019$323,000
+29.7%
2,412
+1.9%
0.00%0.0%
Q3 2019$249,000
-10.1%
2,367
-3.8%
0.00%0.0%
Q2 2019$277,000
+0.7%
2,460
+7.8%
0.00%0.0%
Q1 2019$275,0002,2810.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 11,225,357$1,001,863,11218.92%
Q Global Advisors, LLC 195,000$17,40412.55%
Sofinnova Investments, Inc. 754,032$67,297,3564.41%
Avoro Capital Advisors LLC 3,580,555$319,564,5344.34%
Finepoint Capital LP 139,772$12,474,6514.32%
Spyglass Capital Management LLC 657,853$58,713,3804.24%
Saturn V Capital Management LP 78,442$7,000,9483.88%
DAFNA Capital Management LLC 135,212$12,067,6713.30%
ARS Investment Partners, LLC 289,860$25,870,0053.02%
Ghost Tree Capital, LLC 100,000$8,925,0002.95%
View complete list of ASCENDIS PHARMA A/S shareholders